Offers and Promotion
Choose 360° Protection
Interceptor® Plus (milbemycin oxime/praziquantel) offers broad-spectrum protection against all 5 major worms. With the tick and flea efficacy of Credelio® (lotilaner) or Seresto®, this is 360-degree parasite protection.
Rebates for purchasing 360-degree coverage
Visit the Elanco Rebate Center
Redeem rebates here after purchasing product from your retailer or clinic of choice.
Stock up on 360-degree protection
Find a local clinic or online retailer that carries the 360-degree protection of Interceptor Plus and Credelio or Seresto.
Interceptor Plus Indications and Important Safety Information (ISI)
Consumer: Indications
Interceptor Plus prevents heartworm disease and treats and controls adult roundworm, hookworm, whipworm, and tapeworm infections in dogs and puppies 6 weeks or older and 2 pounds or greater.
Important Safety Information for Interceptor Plus
Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, decreased activity, incoordination, weight loss, convulsions, weakness, and salivation. For complete safety information, please see Interceptor Plus product label or ask your veterinarian.
Credelio Indications and Important Safety Information (ISI)
Consumer: Indications for Credelio
Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations and treatment and control of tick infestations (lone star tick, American dog tick, black-legged tick, and brown dog tick) for one month in dogs and puppies 8 weeks and older and 4.4 pounds or greater.
Important Safety Information for Credelio
Lotilaner is a member of the isoxazoline class of drugs. This class has been associated with neurologic adverse reactions including tremors, incoordination, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, increased urination, and diarrhea. For complete safety information, please see Credelio product label or ask your veterinarian.